
|Videos|November 9, 2015
Continuing Treatment in Dementia Patients
Kalin M. Clifford, PharmD, BCPS, discusses the factors should be considered when determining whether or not a patient with advanced dementia should continue taking a memantine or cholinesterase inhibitor.
Advertisement
Kalin M. Clifford, PharmD, BCPS, discusses the factors should be considered when determining whether or not a patient with advanced dementia should continue taking a memantine or cholinesterase inhibitor.
This video was recorded at ASCP's Annual Meeting and Exhibition in Las Vegas, Nevada in October 2015.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
What Pharmacists Should Know About High-Dose Semaglutide’s Safety Profile
2
Pharmacist Interventions Impact Bottom Line in a Neurology Clinic
3
Polycystic Ovary Syndrome Undergoes Name Change: Polyendocrine Metabolic Ovarian Syndrome
4
GLP-1 Receptor Agonists Linked to Improved Survival Outcomes in Breast Cancer
5

































































































































